Literature DB >> 20637786

Structure based prediction of subtype-selectivity for adenosine receptor antagonists.

Vsevolod Katritch1, Irina Kufareva, Ruben Abagyan.   

Abstract

One of the major hurdles in the development of safe and effective drugs targeting G-protein coupled receptors (GPCRs) is finding ligands that are highly selective for a specific receptor subtype. Structural understanding of subtype-specific binding pocket variations and ligand-receptor interactions may greatly facilitate design of selective ligands. To gain insights into the structural basis of ligand subtype selectivity within the family of adenosine receptors (AR: A(1), A(2A), A(2B), and A(3)) we generated 3D models of all four subtypes using the recently determined crystal structure of the A(A2)AR as a template, and employing the methodology of ligand-guided receptor optimization for refinement. This approach produced 3D conformational models of AR subtypes that effectively explain binding modes and subtype selectivity for a diverse set of known AR antagonists. Analysis of the subtype-specific ligand-receptor interactions allowed identification of the major determinants of ligand selectivity, which may facilitate discovery of more efficient drug candidates.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20637786      PMCID: PMC2980563          DOI: 10.1016/j.neuropharm.2010.07.009

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  38 in total

Review 1.  Prediction of the binding energy for small molecules, peptides and proteins.

Authors:  M Schapira; M Totrov; R Abagyan
Journal:  J Mol Recognit       Date:  1999 May-Jun       Impact factor: 2.137

2.  Comparative study of several algorithms for flexible ligand docking.

Authors:  Badry D Bursulaya; Maxim Totrov; Ruben Abagyan; Charles L Brooks
Journal:  J Comput Aided Mol Des       Date:  2003-11       Impact factor: 3.686

Review 3.  A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists.

Authors:  G Cristalli; C Lambertucci; G Marucci; R Volpini; D Dal Ben
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 4.  Adenosine A2A receptors and Parkinson's disease.

Authors:  Micaela Morelli; Anna R Carta; Peter Jenner
Journal:  Handb Exp Pharmacol       Date:  2009

Review 5.  Adenosine receptors and the central nervous system.

Authors:  Ana M Sebastião; Joaquim A Ribeiro
Journal:  Handb Exp Pharmacol       Date:  2009

6.  1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.

Authors:  Thomas Borrmann; Sonja Hinz; Daniela C G Bertarelli; Wenjin Li; Nicole C Florin; Anja B Scheiff; Christa E Müller
Journal:  J Med Chem       Date:  2009-07-09       Impact factor: 7.446

Review 7.  GPCR agonists and antagonists in the clinic.

Authors:  Joel D A Tyndall; Radhika Sandilya
Journal:  Med Chem       Date:  2005-07       Impact factor: 2.745

Review 8.  Adenosine receptor agonists: from basic medicinal chemistry to clinical development.

Authors:  Luo Yan; Joachim C Burbiel; Astrid Maass; Christa E Müller
Journal:  Expert Opin Emerg Drugs       Date:  2003-11       Impact factor: 4.191

9.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

10.  A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines.

Authors:  Jacobus P D van Veldhoven; Lisa C W Chang; Jacobien K von Frijtag Drabbe Künzel; Thea Mulder-Krieger; Regina Struensee-Link; Margot W Beukers; Johannes Brussee; Adriaan P IJzerman
Journal:  Bioorg Med Chem       Date:  2008-01-12       Impact factor: 3.641

View more
  25 in total

1.  Molecular mechanism of serotonin transporter inhibition elucidated by a new flexible docking protocol.

Authors:  Mari Gabrielsen; Rafał Kurczab; Aina W Ravna; Irina Kufareva; Ruben Abagyan; Zdzisław Chilmonczyk; Andrzej J Bojarski; Ingebrigt Sylte
Journal:  Eur J Med Chem       Date:  2011-10-20       Impact factor: 6.514

2.  The second extracellular loop of the adenosine A1 receptor mediates activity of allosteric enhancers.

Authors:  Dylan P Kennedy; Fiona M McRobb; Susan A Leonhardt; Michael Purdy; Heidi Figler; Melissa A Marshall; Mahendra Chordia; Robert Figler; Joel Linden; Ruben Abagyan; Mark Yeager
Journal:  Mol Pharmacol       Date:  2013-11-11       Impact factor: 4.436

3.  Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges.

Authors:  Irina Kufareva; Vsevolod Katritch; Raymond C Stevens; Ruben Abagyan
Journal:  Structure       Date:  2014-07-24       Impact factor: 5.006

4.  Structure of an agonist-bound human A2A adenosine receptor.

Authors:  Fei Xu; Huixian Wu; Vsevolod Katritch; Gye Won Han; Kenneth A Jacobson; Zhan-Guo Gao; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2011-03-10       Impact factor: 47.728

Review 5.  Structure-function of the G protein-coupled receptor superfamily.

Authors:  Vsevolod Katritch; Vadim Cherezov; Raymond C Stevens
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012-11-08       Impact factor: 13.820

Review 6.  The GPCR Network: a large-scale collaboration to determine human GPCR structure and function.

Authors:  Raymond C Stevens; Vadim Cherezov; Vsevolod Katritch; Ruben Abagyan; Peter Kuhn; Hugh Rosen; Kurt Wüthrich
Journal:  Nat Rev Drug Discov       Date:  2012-12-14       Impact factor: 84.694

7.  Ligand-, structure- and pharmacophore-based molecular fingerprints: a case study on adenosine A(1), A (2A), A (2B), and A (3) receptor antagonists.

Authors:  Francesco Sirci; Laura Goracci; David Rodríguez; Jacqueline van Muijlwijk-Koezen; Hugo Gutiérrez-de-Terán; Raimund Mannhold
Journal:  J Comput Aided Mol Des       Date:  2012-10-12       Impact factor: 3.686

8.  Docking to multiple pockets or ligand fields for screening, activity prediction and scaffold hopping.

Authors:  Yu-Chen Chen; Max Totrov; Ruben Abagyan
Journal:  Future Med Chem       Date:  2014       Impact factor: 3.808

Review 9.  Diversity and modularity of G protein-coupled receptor structures.

Authors:  Vsevolod Katritch; Vadim Cherezov; Raymond C Stevens
Journal:  Trends Pharmacol Sci       Date:  2011-10-25       Impact factor: 14.819

10.  Structure-activity relationships and molecular modeling of 1,2,4-triazoles as adenosine receptor antagonists.

Authors:  Jens Carlsson; Dilip K Tosh; Khai Phan; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  ACS Med Chem Lett       Date:  2012-07-30       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.